Silver Spring (3)

Legon (1)

Plasmodium Falciparum Malaria (3)

Malaria (1)

Completed (2)

Withdrawn (1)

phase 1/phase 2 (2)

phase 1 (1)

U.S. Army Medical Research and Development Command (2)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

GlaxoSmithKline (2)

The PATH Malaria Vaccine Initiative (MVI) (2)

Walter Reed Army Institute of Research (WRAIR) (2)

falciparum malaria protein 11 with as01b adjuvant. (1)

falciparum malaria protein 11 with as02a adjuvant (1)

mva-cso vaccine (1)

pfcsp dna (vcl-2510) vaccine (1)

biological (3)

U.S. Fed (2)

NIH (1)

Interventional (3)

Plasmodium Falciparum Malaria

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS